← All trials
NCT05112913
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 27, 2021
- Primary completion
- Nov 17, 2021
- Completion date
- Jun 25, 2022
- First posted
- Nov 9, 2021
- Last posted
- Nov 9, 2021
- Enrollment
- 2520
- Arms / groups
- 7 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Sinovac Biotech Co., LtdLead sponsor
- Government of ChinaOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.